A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

被引：1
|
作者：
Dispenzieri, Angela
Gertz, Morie Abraham [1 ]
Lacy, Martha Q.
Laumann, Kristina [2 ]
LaPlant, Betsy R.
Kumar, Shaji [1 ]
Buadi, Francis K.
Hayman, Suzanne R. [1 ]
Dingli, David
Hogan, William J.
Ansell, Stephen M. [1 ]
Gastineau, Dennis A.
Inwards, David James [1 ]
Micallef, Ivana N. [1 ]
Porrata, Luis F. [1 ]
Johnston, Patrick B. [1 ]
Litzow, Mark R. [1 ]
Witzig, Thomas E. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Canc Ctr Stat, Rochester, MN USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1337 / 1338
页数：2
相关论文
共 50 条
  • [41] High-Dose Gemcitabine Combined With Busulfan and Melphalan (Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Refractory and Relapsed Myeloma
    Nieto, Yago
    Shah, Nina
    Popat, Uday R.
    Jones, Roy B.
    Bashir, Qaiser
    Bassett, Rolland
    Valdez, Benigno C.
    Andersson, Bone S.
    Parmar, Simrit
    Orlowski, Robert Z.
    Shah, Jatin J.
    Thomas, Sheeba K.
    Wang, Michael
    Champlin, Richard E.
    Qazilbash, Muzaffar
    BLOOD, 2013, 122 (21)
  • [42] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [43] Superior Incidence of Progression-Free Survival (PFS) Following High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM) Patients Receiving Pre-Transplant Induction with IMiDs Versus Conventional VAD Induction Chemotherapy
    Holland, H. Kent
    Solomon, Scott R.
    Bashey, Asad
    Morris, Lawrence E.
    BLOOD, 2008, 112 (11) : 1146 - 1146
  • [44] Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma
    Abidi, Muneer H.
    Gul, Zartash
    Abrams, Judith
    Ayash, Lois
    Deol, Abhinav
    Ventimiglia, Marie
    Lum, Lawrence
    Mellon-Reppen, Stephanie
    Al-Kadhimi, Zaid
    Ratanatharathorn, Voravit
    Zonder, Jeffrey
    Uberti, Joseph
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (03) : 167 - 172
  • [45] Phase I/II trial of high-dose melphalan (M) and topotecan (T) followed by autologous stem cell rescue in patients ≤ 60 and > 60 years of age with multiple myeloma (MM)
    Sullivan, Daniel
    Alsina, Melissa
    Anasetti, Claudio
    Field, Teresa
    Kharfan-Dabaja, Mohamed
    Fernandez, Hugo
    Dalton, William
    Ayala, Ernesto
    Raychaudhuri, Jyoti
    Perez, Lia
    Perkins, Janelle
    Schell, Michael
    McIsaac, Christine
    Maddox, Beth
    Gump, Jana
    Lush, Richard
    Frudakis, Tony
    BLOOD, 2007, 110 (11) : 286A - 287A
  • [46] Lenalidomide (LEN) Maintenance Following High-Dose Melphalan and Autologous Stem Cell Transplant (ASCT) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): A Meta-Analysis of Overall Survival (OS)
    McCarthy, Philip
    Holstein, Sarah
    Petrucci, Maria Teresa
    Richardson, Paul
    Hulin, Cyrille
    Tosi, Patrizia
    Bringhen, Sara
    Musto, Pellegrino
    Anderson, Kenneth C.
    Caillot, Denis
    Gay, Francesca
    Moreau, Philippe
    Marit, Gerald
    Jung, Sin-Ho
    Yu, Zhinuan
    Winograd, Benjamin
    Knight, Robert
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E6 - E6
  • [47] A phase I/II study of 166Holmium-DOTMP in combination with high dose chemotherapy and autologous stem cell transplant (ASCT) for the treatment of patients with multiple myeloma (MM)
    Bensinger, W
    Giralt, S
    Eary, J
    Podoloff, D
    Holmberg, L
    Alexanian, R
    Goodman, M
    Serafini, A
    Thoelke, K
    Bryan, JK
    Champlin, R
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 56 - 56
  • [48] The influence of autologous stem cell transplant (ASCT) on survival in older adults with multiple myeloma (MM).
    Wildes, Tanya Marya
    Finney, Joseph D.
    Fiala, Mark
    Gao, Feng
    Vij, Ravi
    Stockerl-Goldstein, Keith
    Carson, Kenneth Robert
    Colditz, Graham A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Overcoming the Effect of Racial Disparities in Multiple Myeloma (MM) with Autologous Stem Cell Transplant (ASCT)
    Bumma, Naresh
    Zhao, Qiuhong
    Khan, Abdullah
    Chaudhry, Maria
    Sharma, Nidhi
    Rosko, Ashley
    Benson, Don M.
    Efebera, Yvonne A.
    Devarakonda, Srinivas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S235 - S236
  • [50] High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma
    T M Wildes
    J D Finney
    M Fiala
    F Gao
    R Vij
    K Stockerl-Goldstein
    K R Carson
    J Mikhael
    G Colditz
    Bone Marrow Transplantation, 2015, 50 : 1075 - 1082
12345